MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $14.58 Million Stake in Danaher Co. (NYSE:DHR)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Danaher Co. (NYSE:DHR) by 7.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 63,534 shares of the conglomerate’s stock after purchasing an additional 4,388 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Danaher were worth $14,584,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Gilbert & Cook Inc. raised its position in shares of Danaher by 2.5% during the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after purchasing an additional 42 shares during the period. Grimes & Company Inc. raised its position in Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock valued at $1,696,000 after buying an additional 43 shares during the last quarter. Dakota Community Bank & Trust NA raised its position in Danaher by 16.4% in the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after buying an additional 45 shares during the last quarter. Spinnaker Trust raised its position in Danaher by 1.2% in the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after buying an additional 50 shares during the last quarter. Finally, Fortis Capital Advisors LLC raised its position in Danaher by 1.3% in the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock valued at $914,000 after buying an additional 50 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the firm’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman now owns 3,105,808 shares of the company’s stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DHR. Guggenheim reissued a “buy” rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a research report on Friday, March 14th. UBS Group lowered their price target on Danaher from $275.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Raymond James reissued a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Finally, StockNews.com upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Monday. Four research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average target price of $264.40.

Danaher Stock Up 1.6%

DHR stock opened at $190.87 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a market capitalization of $136.60 billion, a price-to-earnings ratio of 36.15, a PEG ratio of 2.66 and a beta of 0.80. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The stock has a fifty day moving average of $197.06 and a 200-day moving average of $217.96.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. As a group, equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.67%. Danaher’s dividend payout ratio (DPR) is 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.